[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"updates-archive-2026-03-10-9":3},{"date":4,"filings":5,"has_more":66,"limit":67,"page":68,"total_count":69},"2026-03-10",[6,14,18,22,26,33,36,43,47,53,57,62],{"company_name":7,"filing_date":8,"filing_source":9,"headline":10,"id":11,"stock_code":12,"summary_text":13},"CreditAccess Grameen Ltd","2026-03-10T07:50:46.237000","BSE","CreditAccess Grameen Secures USD 75 Million Syndicated Social Loan","69af8061e403466c66a2c9e9","541770","*   The company has raised USD 75 million through a syndicated social loan facility, qualifying as an External Commercial Borrowing (ECB) under RBI's automatic route.\n*   HSBC acted as the sole lead arranger, with participation from international banks including Doha Bank, State Bank (Mauritius), Bank of China, and National Development Bank (Sri Lanka).\n*   Proceeds will be used for eligible social projects under the company's Social Loan Framework, which has been validated by Sustainalytics.\n*   This transaction brings total international commitments for FY 2025-26 to over USD 300 million.\n*   The CFO stated the new 3-5 year tenure loan enhances the company's asset-liability management (ALM) and liquidity, helping to reduce the cost of funds and support financial inclusion.",{"company_name":7,"filing_date":8,"filing_source":9,"headline":15,"id":16,"stock_code":12,"summary_text":17},"CreditAccess Grameen Secures USD 75 Million Syndicated Social Loan Facility","69af80624f5d9594509b5de6","*   The company has signed a USD 75 million Syndicated Social Loan Facility, qualifying as an External Commercial Borrowing (ECB) under the RBI's automatic route.\n*   HSBC acted as the Sole Mandated Lead Arranger and Bookrunner. Participating lenders include HSBC, Doha Bank, State Bank of Mauritius, Bank of China, and National Development Bank Plc.\n*   Proceeds will be deployed for eligible social projects under the company's Social Loan Framework, which has been validated by Sustainalytics.\n*   This transaction brings total commitments from global institutions in FY 2025-26 to over USD 300 million.\n*   The company's share of foreign borrowings has increased from 9% to 24% over the past five years, with the new 3-5 year tenure facility enhancing its asset-liability management (ALM) profile.",{"company_name":7,"filing_date":8,"filing_source":9,"headline":19,"id":20,"stock_code":12,"summary_text":21},"Secures USD 75 Million Syndicated Social Loan to Boost Inclusive Growth","69af80639c638ecba7a2b635","*   Raised a USD 75 million syndicated social loan facility, qualifying as an External Commercial Borrowing (ECB) under the RBI's automatic route.\n*   The transaction was led by HSBC as the Sole Mandated Lead Arranger and Bookrunner, with participation from Doha Bank, State Bank (Mauritius), Bank of China, and National Development Bank Plc (Sri Lanka).\n*   This brings the company's total foreign funding commitments for FY 2025-26 to over USD 300 million, with foreign sources now accounting for over 15% of its borrowing requirements for the fiscal year.\n*   The proceeds will be deployed under the company's Social Loan Framework, which is validated by Sustainalytics, to fund eligible social projects aimed at inclusive development.\n*   According to the CFO, the 3-5 year tenure of this foreign currency loan significantly enhances the company's asset-liability management (ALM) profile and liquidity.\n*   This move is part of a broader strategy that has seen the share of foreign borrowings in the company's portfolio increase from 9% to 24% over the past five years.",{"company_name":7,"filing_date":8,"filing_source":9,"headline":23,"id":24,"stock_code":12,"summary_text":25},"Secures USD 75 Million Syndicated Social Loan Facility","69af806b0fec63795b0de6dc","*   *Secured a USD 75 million syndicated social loan, qualifying as an External Commercial Borrowing (ECB) under the RBI's automatic route.*\n*   *The fundraising was arranged by HSBC and saw participation from a diverse group of international lenders, including Doha Bank, Bank of China, and State Bank of Mauritius.*\n*   *Proceeds will be deployed under the company's Social Loan Framework, which has been validated by Sustainalytics, to fund eligible social projects and advance financial inclusion.*\n*   *This transaction brings the company's total foreign fund commitments for FY 2025-26 to over USD 300 million, with foreign sources now meeting over 15% of its borrowing needs.*\n*   *According to the CFO, the 3-5 year tenure of the loan significantly enhances the company's asset-liability management (ALM) profile and liquidity position.*",{"company_name":27,"filing_date":28,"filing_source":29,"headline":23,"id":30,"stock_code":31,"summary_text":32},"CREDITACCESS GRAMEEN LIMITED","2026-03-10T07:45:46.728000","NSE","69af7f364f5d9594509b5de4","CREDITACC","*   The company has signed a USD 75 million syndicated social loan, qualifying as an External Commercial Borrowing (ECB) under the RBI's automatic route.\n*   HSBC acted as the Sole Mandated Lead Arranger and Bookrunner, with participation from several international banks.\n*   Proceeds will be deployed under the company's Social Loan Framework to fund eligible social projects, advancing its mission of financial inclusion.\n*   This transaction brings total commitments from global sources to over USD 300 million in FY 2025-26.\n*   The CFO stated the 3-5 year tenure of the loan significantly enhances the company's asset-liability management (ALM) profile and liquidity position.",{"company_name":27,"filing_date":28,"filing_source":29,"headline":10,"id":34,"stock_code":31,"summary_text":35},"69af7f39303160d411228967","*   The company has signed a USD 75 million syndicated social loan facility, qualifying as an External Commercial Borrowing (ECB) under the RBI's automatic route.\n*   HSBC acted as the Sole Mandated Lead Arranger and Bookrunner, with participation from banks in Qatar, Mauritius, China, and Sri Lanka.\n*   Proceeds will be deployed under the company's Social Loan Framework to fund eligible social projects, a framework validated by Sustainalytics.\n*   This transaction is part of over USD 300 million in commitments raised from global institutions in FY 2025-26, meeting over 15% of its borrowing needs for the year from foreign sources.\n*   According to the CFO, the 3-5 year tenure of the loan significantly enhances the company's asset-liability management (ALM) and liquidity, while increasing the share of foreign borrowings from 9% to 24% over the past five years.",{"company_name":37,"filing_date":38,"filing_source":29,"headline":39,"id":40,"stock_code":41,"summary_text":42},"Trigyn Technologies Limited","2026-03-10T00:40:46.492000","Trigyn Announces Resignation of Chairman Dr. Satyam Cherukuri","69af1b58e403466c66a2c973","TRIGYN","*   Dr. Satyam Cherukuri has resigned from his positions as Chairman and Non-Executive Non-Independent Director.\n*   The resignation is effective from a future date: April 7, 2026.\n*   The company has cited \"Resignation\" as the reason for the change.\n*   The unusually long notice period suggests a planned and structured leadership transition.",{"company_name":37,"filing_date":38,"filing_source":29,"headline":44,"id":45,"stock_code":41,"summary_text":46},"Chairman Dr. Satyam Cherukuri Announces Resignation, Effective 2026","69af1b624f5d9594509b5d70","*   Dr. Satyam Cherukuri has submitted his resignation from the roles of Chairman and Non-Executive Non-Independent Director.\n*   The resignation will be effective from a future date: April 7, 2026.\n*   The long notice period suggests a planned leadership transition, allowing ample time for succession planning.",{"company_name":48,"filing_date":49,"filing_source":9,"headline":50,"id":51,"stock_code":41,"summary_text":52},"Trigyn Technologies Ltd","2026-03-10T00:20:46.767000","Chairman Dr. Satyam Cherukuri Tenders Resignation","69af16e34f5d9594509b5d65","*   Dr. Satyam Cherukuri has resigned from his position as Chairman and Non-Executive Director of the Board, effective April 7, 2026.\n*   The resignation is cited as being due to \"personal circumstances requiring his full attention and commitment.\"\n*   He will also step down as a Member of the Board of the company's subsidiary, Trigyn Technologies Inc., on the same date.\n*   The company has filed this update with the BSE and NSE as required under SEBI's LODR regulations.\n*   Dr. Cherukuri has committed to ensuring a smooth and orderly transition of leadership.",{"company_name":48,"filing_date":49,"filing_source":9,"headline":54,"id":55,"stock_code":41,"summary_text":56},"Chairman Dr. Satyam Cherukuri Announces Resignation","69af16e80fec63795b0de665","*   Dr. Satyam Cherukuri has tendered his resignation as Chairman and Non-Executive Director of the Board.\n*   He will also step down as a Member of the Board of the company's subsidiary, Trigyn Technologies Inc.\n*   The resignation will be effective from April 7, 2026.\n*   The reason cited is personal commitments requiring his time and attention.",{"company_name":48,"filing_date":58,"filing_source":9,"headline":59,"id":60,"stock_code":41,"summary_text":61},"2026-03-10T00:20:46.765000","Trigyn Technologies Announces Resignation of Chairman Dr. Satyam Cherukuri","69af16e7e403466c66a2c96c","*   Dr. Satyam Cherukuri has tendered his resignation from the position of Chairman and Non-Executive Director, effective April 7, 2026.\n*   He has also stepped down as a Member of the Board of the company's subsidiary, Trigyn Technologies Inc.\n*   The reason cited for the resignation is \"personal circumstances requiring his full attention and commitment.\"\n*   The company expressed its appreciation for his contributions and noted his commitment to ensuring a smooth transition.",{"company_name":48,"filing_date":58,"filing_source":9,"headline":63,"id":64,"stock_code":41,"summary_text":65},"Chairman and Director Dr. Satyam Cherukuri Resigns","69af16ea303160d4112288f8","*   Dr. Satyam Cherukuri has tendered his resignation as Chairman and Non-Executive Director of the company.\n*   He is also stepping down as a Member of the Board of the US subsidiary, Trigyn Technologies Inc.\n*   The resignation, due to personal commitments, will be effective from April 7, 2026.\n*   Dr. Cherukuri has committed to ensuring a smooth and orderly leadership transition.",false,100,9,812]